< Back to Search

Neurology® Neuroimmunology & Neuroinflammation Podcast - October 2014 Issue

Treatment resistant immune thrombocytopenic purpura

Ransohoff, Editor of Neurology: Neuroimmunology & Neuroinfammation introduces the podcast initiative and the following interview. Dr. Scott Zamvil then interviews Dr. Oivind Torkildsen about his paper on treatment resistant immune thrombocytopenic purpura associated with low-dose naltrezone use in a patient with MS. Richard M. Ransohoff conducts research supported by the NIH, the National MS Society, the DOD, the Alzheimer's Association, the Guthy-Jackson Foundation, Williams Family Foundation for MS Research, ChemoCentryx, Lundbeck, Teva, Novartis, Genzyme, and Biogen-Idec. Dr. Ransohoff has received fees for preclinical consul Read More

Download this Episode

Episode Segments

Introduction (00:17 - 01:51)
00:17 01:51

Play Segment

Interview: Treatment-resistant immune thrombocytopenic purpura associated with LDN use in a patient with MS (01:52 - 10:52)
Closing (10:53 - 11:50)
10:53 11:50

Play Segment

Log On


Forgot password?